Liu, H., X. Zhou, H. Jiang, H. He, X. Liu, M. W. Weiner, P. Aisen, et al. 2016. “A semi-mechanism approach based on MRI and proteomics for prediction of conversion from mild cognitive impairment to Alzheimer’s disease.” Scientific Reports 6 (1): 26712. doi:10.1038/srep26712. http://dx.doi.org/10.1038/srep26712.
Xu, W., H. Wang, L. Tan, M. Tan, C. Tan, X. Zhu, D. Miao, et al. 2016. “The impact of PICALM genetic variations on reserve capacity of posterior cingulate in AD continuum.” Scientific Reports 6 (1): 24480. doi:10.1038/srep24480. http://dx.doi.org/10.1038/srep24480.
Tan, L., H. Wang, M. Tan, C. Tan, X. Zhu, D. Miao, W. Yu, et al. 2016. “Effect of CLU genetic variants on cerebrospinal fluid and neuroimaging markers in healthy, mild cognitive impairment and Alzheimer’s disease cohorts.” Scientific Reports 6 (1): 26027. doi:10.1038/srep26027. http://dx.doi.org/10.1038/srep26027.
Iturria-Medina, Y., R. C. Sotero, P. J. Toussaint, J. M. Mateos-Pérez, A. C. Evans, M. W. Weiner, P. Aisen, et al. 2016. “Early role of vascular dysregulation on late-onset Alzheimer's disease based on multifactorial data-driven analysis.” Nature Communications 7 (1): 11934. doi:10.1038/ncomms11934. http://dx.doi.org/10.1038/ncomms11934.
Ayton, S., N. G. Faux, A. I. Bush, M. W. Weiner, P. Aisen, R. Petersen, C. R. Jack Jr., et al. 2015. “Ferritin levels in the cerebrospinal fluid predict Alzheimer's disease outcomes and are regulated by APOE.” Nature Communications 6 (1): 6760. doi:10.1038/ncomms7760. http://dx.doi.org/10.1038/ncomms7760.